Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma.
Tobinai K, Igarashi T, Itoh K, Kobayashi Y, Taniwaki M, Ogura M, Kinoshita T, Hotta T, Aikawa K, Tsushita K, Hiraoka A, Matsuno Y, Nakamura S, Mori S, Ohashi Y; IDEC-C2B8 Japan Study Group.
Tobinai K, et al. Among authors: igarashi t.
Ann Oncol. 2004 May;15(5):821-30. doi: 10.1093/annonc/mdh176.
Ann Oncol. 2004.
PMID: 15111353
Free article.
Clinical Trial.